India | UK | US

St. Jude Medical earnings rise on ICD rebound

Posted : Wed, 16 Jul 2008 11:43:03 GMT
Author : Reuters
Category : US (Business)
News Alerts by Email ( click here )
US Business News | Home
CHICAGO (Reuters) - St. Jude Medical Inc on Wednesday said quarterly earnings rose as sales of its implantable cardioverter defibrillators, or ICDs, rose 24 percent over a year ago.

The cardiovascular device maker, which also raised its outlook for the full year, said second-quarter net earnings were $208.5 million, or 58 cents per share, compared with a profit of $134.8 million, or 39 cents per share, in the year-ago quarter.

Net profit in the year-ago quarter was reduced by special charges for settling patent litigation.

In the latest quarter, analysts on average expected St. Paul, Minnesota-based St. Jude to earn 55 cents per share, according to Reuters Estimates.

(Reporting by Debra Sherman; Editing by Derek Caney)


(c) Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Share/Save/Bookmark

Article : St. Jude Medical earnings rise on ICD rebound
Print this article
Email this article

Stay Updated
News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 

 

More US (Business) News click here
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark

 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.